Open AccessCorrelation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer’s Disease and Normal Brain
Author(s) -
Jieun Jeong,
Young Jin Jeong,
Kyung Won Park
Publication year - 2019
Publication title -
nuclear medicine and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.534
H-Index - 23
eISSN - 1869-3482
pISSN - 1869-3474
DOI - 10.1007/s13139-019-00612-y
Subject(s) - medicine , nuclear medicine , positron emission tomography , standardized uptake value , normalization (sociology) , correlation , correlation coefficient , fluorodeoxyglucose , dementia , pearson product moment correlation coefficient , disease , mathematics , statistics , geometry , sociology , anthropology
F-18 florapronol (FPN) is the commercially recognized beta-amyloid positron emission tomography (PET) radiotracer in Korea. This study compared the early F-18 florapronol PET with F-18 fluorodeoxyglucose (FDG) PET between healthy controls (HC) and Alzheimer's dementia (AD) patients.